NEXN-AS1

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, NEXN-AS1 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated NEXN-AS1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher NEXN-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated NEXN-AS1 expression acts as an unfavorable survival marker, although some lineages such as UCS and BRCA show a favorable association.

KIRC, UVM, and UCS are the cancer types where NEXN-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
KIRCDFSMedianII,III,IV0.4120.623<.00186view →
UVMOSMedianIII,IV0.3990.794.00152view →
UCSDFSMedianII,III,IV0.6260.246<.00146view →
BRCAOSMedianIII,IV0.8880.775.00443view →
LGGDFSMedianAll0.6400.824<.00140view →
UCECDFSTertileAll0.7820.862.01526view →
SKCMOSMedianII,III,IV0.4760.282.00224view →
LIHCOSTertileAll0.6730.840.00321view →
CESCDFSTertileIII,IV0.5240.831.00618view →
THCAOSTertileII,III,IV0.9460.994.01016view →
LAMLDFSMedianAll0.4540.694.0098view →
OVOSTertileIII,IV0.8030.863.0306view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

NEXN-AS1–KIRC (DFS)

Kaplan–Meier survival curve for NEXN-AS1 RNA-high vs -low samples in KIRC.

Open the KIRC breakdown →

Exploration